A placebo-controlled, ascending single-dose study to evaluate the safety and pharmacokinetics of VGX-1027 in healthy subjects

Trial Profile

A placebo-controlled, ascending single-dose study to evaluate the safety and pharmacokinetics of VGX-1027 in healthy subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Apr 2016

At a glance

  • Drugs VGX 1027 (Primary)
  • Indications Rheumatoid arthritis; Type 1 diabetes mellitus
  • Focus Adverse reactions
  • Sponsors VGX Pharmaceuticals
  • Most Recent Events

    • 01 Mar 2016 Results from this and the other phase I study, published in the Clinical Pharmacology in Drug Development.
    • 08 Jan 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 18 May 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top